Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Cardiology | Endocrinology | Family Medicine | Internal Medicine | Nursing | Oncology | Pathology | Journal

Back to Journal Articles

Genetic Testing Doesn’t Up Post-Test Health Care Use

Last Updated: May 23, 2012.

 

But individuals who complete multiplex genetic testing have more physician visits pre-test

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Receiving genetic susceptibility testing is associated with an increase in physician visits before testing, but does not impact subsequent health care utilization, according to a study published online May 17 in Genetics in Medicine.

WEDNESDAY, May 23 (HealthDay News) -- Receiving genetic susceptibility testing is associated with an increase in physician visits before testing, but does not impact subsequent health care utilization, according to a study published online May 17 in Genetics in Medicine.

Robert J. Reid, M.D., Ph.D., from the Group Health Research Institute in Seattle, and colleagues surveyed 1,599 adults (aged 25 to 40 years) and offered them multiplex genetic susceptibility testing for eight common health conditions. Electronic health records were used to determine health-care utilization in the 12-month pre- and post-test periods for those who completed a baseline survey only (68.7 percent), those who visited the study Web site and decided not to undergo testing (17.8 percent), and those who underwent the multiplex genetic test (13.6 percent).

The researchers found that those who chose the multiplex testing had an average of 1.02 physician visits per quarter in the pre-test period, compared with 0.93 visits for those who only participated in the survey and 0.82 for those who visited the Web site (P < 0.05). For four common health conditions, there were no significant differences in the pre-test use of any common medical tests or procedures. In the post-test period there were no statistically significant differences in any utilization category by group.

"This study supports the supposition that multiplex genetic testing offers can be provided directly to the patients in such a way that use of health services is not inappropriately increased," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Characteristics of STEMI Reperfusion Systems Identified Next: Regorafenib Active in Metastatic GI Stromal Tumors

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.